改良QUAD SHOT方案放疗能否有效姑息口腔癌?治疗结局分析
本研究回顾性分析116例不可手术头颈癌患者,采用每日3.6-3.7 Gy、连续4天、共3程、每程间隔2周的改良QUAD SHOT方案放疗,85%完成3程,总主观缓解率77%,中位总生存12个月,中位无进展生存8个月,口腔癌亚组总生存数值更高,治疗耐受良好。
要点
- 改良QUAD SHOT方案:每日3.6-3.7 Gy,连续4天,共3程,每程间隔2周。
- 116例中85%完成3程,总主观缓解率77%。
- 中位总生存12个月,中位无进展生存8个月,口腔癌总生存数值更高。
核心结论
- 改良QUAD SHOT方案用于头颈癌姑息治疗是可行的。
研究设计与样本
- 回顾性分析116例接受改良QUAD SHOT方案放疗的不可手术头颈癌患者,并对口腔癌进行亚组分析。
主要发现
- 99例(85%)完成3程治疗。
- 总主观缓解率为77%。
- 中位总生存为12个月(95%CI:8-20),中位无进展生存为8个月(95%CI:6-10)。
- 口腔癌亚组的总生存数值更高。
- 治疗耐受良好,无治疗期间住院或3-4级毒性。
关键数值与推荐
- 放疗方案为每日3.6-3.7 Gy,连续4天,共3程,每程间隔2周。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study assessed a palliative radiotherapy regimen using daily radiation over 4 days for three courses in inoperable head and neck cancers, emphasizing oral primary cancers. METHODS: Retrospective data of 116 patients treated with a daily dose of 3.6-3.7 Gy in four fractions over 4 days to a total of three courses, with a 2-week gap after every course, were analyzed for survival outcomes. A subgroup analysis was done for oral cancer. RESULTS: Ninety-nine (85%) completed three courses. Overall subjective response rate was 77%. Median overall survival and progression-free survival were 12 months (95% confidence interval [CI]: 8-20) and 8 months (95% CI: 6-10), with numerically higher overall survival in oral cancer. The treatment was well tolerated, with no on-treatment hospitalization or grade 3-4 toxicities. CONCLUSION: The modified QUAD SHOT regimen is practical for palliation in head and neck cancers.
引用
- Saha S, Mallick I, Mukherjee P, et al. Are oral cancers effectively palliated with radiotherapy? Outcomes of treatment with a modified QUAD SHOT regimen. Head Neck. 2024. PMID: 38528774. doi:10.1002/hed.27730
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。